The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Understanding the expanding armamentarium for GIST: Engaged learning outcomes.
 
Michelle Arielle Worst
No Relationships to Disclose
 
Emily Sherene Van Laar
No Relationships to Disclose
 
Mindy Tanzola
No Relationships to Disclose
 
Michael C. Heinrich
Stock and Other Ownership Interests - MolecularMD; MolecularMD; MolecularMD; MolecularMD
Honoraria - Novartis; Novartis; Novartis; Novartis
Consulting or Advisory Role - Bayer; Bayer; Bayer; Bayer; Blueprint Medicines; Blueprint Medicines; Blueprint Medicines; Blueprint Medicines; Deciphera; Deciphera; Deciphera; Deciphera; MolecularMD; MolecularMD; MolecularMD; MolecularMD; Novartis; Novartis; Novartis; Novartis; Pfizer; Pfizer; Pfizer; Pfizer
Research Funding - Blueprint Medicines (Inst); Blueprint Medicines (Inst); Blueprint Medicines (Inst); Blueprint Medicines (Inst); Deciphera (Inst); Deciphera (Inst); Deciphera (Inst); Deciphera (Inst)
Patents, Royalties, Other Intellectual Property - Patent on treatment of GIST-licensed to Novartis (Inst); Patent on treatment of GIST-licensed to Novartis (Inst); Patent on treatment of GIST-licensed to Novartis (Inst); Patent on treatment of GIST-licensed to Novartis (Inst)
Expert Testimony - Novartis; Novartis; Novartis; Novartis
 
Victor Manuel Villalobos
Consulting or Advisory Role - Abbvie; Abbvie; Abbvie; Abbvie; Agios; Agios; Agios; Agios; Epizyme; Epizyme; Epizyme; Epizyme; Ignyta; Ignyta; Ignyta; Ignyta; Janssen; Janssen; Janssen; Janssen; Lilly; Lilly; Lilly; Lilly; Novartis; Novartis; Novartis; Novartis
Travel, Accommodations, Expenses - Epizyme; Epizyme; Epizyme; Epizyme; GenMab; GenMab; GenMab; GenMab; Janssen; Janssen; Janssen; Janssen; Lilly; Lilly; Lilly; Lilly; Xencor; Xencor; Xencor; Xencor